The Effect of Eyelid Support Plate Assisted Eyelid Massage on Meibomian Gland Dysfunction: a Randomized Controlled Trial
NCT07633938 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142
Last updated 2026-06-11
Summary
This study aims to conduct a randomized controlled clinical trial to compare the efficacy of a new type of massage device - eyelid support plate and glass rod assisted eyelid massage in improving MGD related dry eye symptoms, and evaluate the comfort and efficiency of both treatments, providing evidence-based support for clinical work
Conditions
- Dry Eye Disease (DED)
- MGD-Meibomian Gland Dysfunction
Interventions
- PROCEDURE
-
eyelid support plate assisted eyelid massage
The participants of experimental group receive sodium hyaluronate eye drops in both eyes four times a day for 8 weeks, and receive eyelid support plate assisted eyelid massage based on the group standard of Meibomian gland massage procedure (T/GDPMAA003-2023) every two weeks for a total of four times. Follow up evaluations will be conducted at weeks 4 and 8.
- PROCEDURE
-
glass rod assisted eyelid massage
The participants of control group receive sodium hyaluronate eye drops 4 times a day for 8 weeks, and receive glass rod assisted eyelid massage based on the group standard of "Meibomian gland massage operation procedure" (T/GDPMAA003-2023) every 2 weeks, for a total of 4 times. Follow up evaluations will be conducted at weeks 4 and 8
Sponsors & Collaborators
-
Zhongshan Ophthalmic Center, Sun Yat-sen University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-01
- Primary Completion
- 2027-07-01
- Completion
- 2027-09-01
Countries
- China
Study Locations
More Related Trials
-
Laser Acupuncture for Dry Eye
NCT03204903 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Meibomian Gland Dysfunction and Dry Eye With an LED Blue Treatment Device
NCT03788486 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction
NCT02958514 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Intense Pulsed Light for Improving Dry Eye Syndrome
NCT03396913 ·Status: COMPLETED ·Phase: NA
-
Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD
NCT02621593 ·Status: COMPLETED ·Phase: NA
-
Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease
NCT03658811 ·Status: COMPLETED ·Phase: NA
-
Meibomian Gland Dysfunction Management With ZEST Protocol
NCT03968731 ·Status: COMPLETED ·Phase: NA
-
Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma Drops
NCT03515187 ·Status: UNKNOWN ·Phase: PHASE3
-
The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression
NCT05713981 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Short-term and Long Term Efficacy of Acupuncture in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome
NCT04877483 ·Status: UNKNOWN ·Phase: NA
-
An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake
NCT04280653 ·Status: COMPLETED ·Phase: NA
-
Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment of Dry Eye Disease
NCT07298811 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye
NCT00832130 ·Status: COMPLETED ·Phase: NA
-
EyeBag Effectiveness in Meibomian Gland Dysfunction
NCT01870180 ·Status: COMPLETED ·Phase: NA
-
BroadBand Light for the Treatment of Dry Eye Disease
NCT06174064 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Mechanisms of Light-based Therapies for Dry Eye Disease
NCT06004895 ·Status: COMPLETED ·Phase: NA
-
A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops
NCT06209203 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study
NCT03956225 ·Status: COMPLETED ·Phase: NA
-
Evaluating Impact of Systane iLux on Dryness Symptoms and Wearing Time in Contact Lens Users
NCT05306561 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients
NCT06942793 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Effect of Gland Expression on the Regeneration of Meibomian Gland
NCT06163105 ·Status: COMPLETED ·Phase: NA
-
Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction
NCT03055832 ·Status: COMPLETED ·Phase: NA
-
Treating Meibomian Gland Disease in a Pediatric Population
NCT07229001 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Dry Eye Under China's Dynamic COVID-zero Strategy
NCT05476068 ·Status: COMPLETED
-
Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease
NCT03502447 ·Status: TERMINATED ·Phase: NA